The Mexico osteoarthritis therapeutics market was valued at USD 122.29 Million in 2024, driven by the rising prevalence of osteoarthritis and increasing awareness and early detection initiatives across the region. The market is anticipated to grow at a CAGR of 3.90% during the forecast period of 2025-2034, with the values likely to reach USD 179.29 Million by 2034. The market is witnessing growth due to rising aging populations, increased healthcare access, and advanced treatment options like biologics.
Base Year
Historical Period
Forecast Period
Osteoarthritis is the most prevalent form of arthritis in Mexico, affecting approximately 20-25% of adults aged 40 and older. This growing incidence significantly drives the expansion of the osteoarthritis therapeutics market.
The growing prevalence of obesity in Mexico is a key driver for the osteoarthritis therapeutics market, as excess weight significantly increases the risk of developing joint degeneration and osteoarthritis.
One of the key trends include a preference towards personalized medicine in the treatment of osteoarthritis. There is a focus on tailored therapies that address individual patient needs based on genetic and lifestyle factors.
Value in USD Million
2025-2034
Mexico Osteoarthritis Therapeutics Market Outlook
*this image is indicative*
A 2025 study published by the University of Texas Medical Branch revealed that osteoarthritis has an estimated prevalence of 20-25% among adults aged 40 and above in region, making it the most common type of arthritis. Osteoarthritis therapeutics involve medications, physical therapy, and surgical interventions to manage joint pain, improve mobility, and slow disease progression. Treatment options include analgesics, nonsteroidal anti-inflammatory drugs, corticosteroids, and disease-modifying therapies. The osteoarthritis therapeutics market in Mexico is growing due to rising obesity rates, an aging population, and increased awareness. The market is anticipated to grow at a CAGR of 3.90% during the forecast period of 2025–2034. Expanding healthcare infrastructure further supports market growth and access to advanced treatments.
Increasing Prevalence of Obesity to Elevate the Market Growth
The rising prevalence of obesity is significantly affecting the demand for osteoarthritis therapeutics, especially among children and the elderly. According to the INSP and ANM, around 14 million children and adolescents in Mexico are overweight (BMI ≥ 25) or obese (BMI ≥ 30). This increasing obesity trend is expected to drive the demand for effective therapeutics, highlighting the growing need for solutions to manage joint pain and improve mobility.
The market is experiencing several notable trends, including the growing adoption of non-surgical treatments and an increase in government efforts to raise awareness about osteoarthritis.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Drug Class
Market Breakup by Dosage Form
Market Breakup by Route of Administration
Market Breakup by End User
Market Breakup by Distribution Channel
Segmentation Based on Type to Witness Substantial Growth
Based on the type, the market is segmented into hip osteoarthritis, spinal osteoarthritis, knee osteoarthritis, hand osteoarthritis, and others. Knee osteoarthritis is expected to lead the market due to its high prevalence, particularly among the aging population. Increased awareness and advanced treatment options are driving the demand for knee osteoarthritis therapies.
The key features of the market report comprise clinical trials analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Founded in 2012 and headquartered in Durham, North Carolina, Bioventus is a global leader in orthobiologics. The company expanded into the Mexican osteoarthritis therapeutics market by introducing Durolane, a single-injection hyaluronic acid treatment for mild to moderate knee osteoarthritis. Distributed through Artimedica SA, Durolane supports Bioventus’ strategy to enhance joint health solutions and reach patients across Latin America.
GSK plc, a leading biopharmaceutical company established in 2000 and headquartered in London, UK, had strengthened its presence in the osteoarthritis therapeutics market through its participation in a global clinical trial. The company trial evaluated the investigational anti-inflammatory drug GW406381 for the treatment of knee osteoarthritis and included a study site in Mexico. This reflects GSK’s strategic efforts at the time to advance osteoarthritis treatment and broaden its reach in the Latin American region.
Sanofi S.A., established in 1973 and headquartered in Paris, France, is a key player in the osteoarthritis therapeutics market in Mexico. The company has advanced its research in osteoarthritis through the development of SAR113945, an investigational intra-articular suspension designed for single-dose knee injections. This therapy was evaluated in clinical trials to assess pain, inflammation, and functional improvement, utilizing biomarkers. Sanofi’s continued engagement reflects its strategic focus on addressing chronic joint conditions, particularly in aging populations prone to osteoarthritis
Novartis AG, established in 1996 and headquartered in Basel, Switzerland, has long been a prominent player in global healthcare. The company made strides in the osteoarthritis therapeutics market with its clinical trials for LNA043, a drug designed to support cartilage repair.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Pfizer Inc., and Bayer AG among others.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Drug Class |
|
| Breakup by Dosage Form |
|
| Breakup by Route of Administration |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share